Listen to this episode with a 7-day free trial
Subscribe to On The Pen to listen to this post and get 7 days of free access to the full post archives.
Share from 0:00
0:00
/
0:00
Paid episode
The full episode is only available to paid subscribers of On The Pen
On The Pen With Dave Knapp
Dave Knapp brings you your weekly dose of everything in the news about incretin mimetic, diabetes and obesity therapies, like Zepbound and Mounjaro, Ozempic and Wegovy, and even investigational treatments like CagriSema and Retatrutide!
Dave Knapp brings you your weekly dose of everything in the news about incretin mimetic, diabetes and obesity therapies, like Zepbound and Mounjaro, Ozempic and Wegovy, and even investigational treatments like CagriSema and Retatrutide!
Appears in episode
On The Pen
Recent Episodes
